EnviroLeach Announces Partnership with Jabil for E-Waste Processing
Aug 31, 2017 11:00 am UTC| Business
VANCOUVER, British Columbia, Aug. 31, 2017 -- EnviroLeach Technologies Inc. (CSE:ETI) (OTCQB:EVLLF), is pleased to announce that it has entered into a strategic global partnership with Jabil Inc. (NYSE:JBL). As part of...
Apricus Biosciences Announces FDA Acknowledgement of Vitaros™ Class 2 NDA Resubmission
Aug 31, 2017 11:00 am UTC| Business
SAN DIEGO, Aug. 31, 2017 -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that the U.S. Food and Drug Administration...
Mersana Therapeutics to Participate in Investor Conferences in September
Aug 31, 2017 11:00 am UTC| Business
CAMBRIDGE, Mass., Aug. 31, 2017 -- Mersana Therapeutics, Inc. (NASDAQ:MRSN) today announced that Anna Protopapas, President and Chief Executive Officer, will participate in three upcoming investor conferences in...
Aug 31, 2017 11:00 am UTC| Business
OXFORD, United Kingdom, Aug. 31, 2017 -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy (‘DMD’) and C. difficile...
Aug 31, 2017 11:00 am UTC| Business
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Aug. 31, 2017 -- Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene...
Akcea and Ionis Announce Submission of New Drug Application for Volanesorsen to the U.S. FDA
Aug 31, 2017 11:00 am UTC| Business
CAMBRIDGE, Mass., Aug. 31, 2017 -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) focused on developing and commercializing drugs to treat patients with serious...
Cesca Therapeutics to Participate in the CAR-TCR Summit 2017
Aug 31, 2017 11:00 am UTC| Business
RANCHO CORDOVA, Calif., Aug. 31, 2017 -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that the Company will...